- 4,885,845 Micropipettes and the fabrication thereof
- 5,370,842 Pipette Puller
- 6,415,679 Manual Drive for Positioning Precision Instruments
- 6,363,750 Automatic Pipette Puller and Forge
- 6,451,262 Dissection Specimen Holder
- 6,513,259 Slide Assembly with Adjustable Resistance
- 7,414,403 Imaging Machine / MRI Positioning Assembly for Magnet Coils and Specimens
- 7,534,067 Coupling Assembly for Animal Management System
- 7,784,429 Contoured Specimen Holder for Imaging Machines
- 7,865,226 Specimen Positioning System for Imaging Machines
- 8,322,310 Specimen alignment and head holding system for imaging machines
- 8,327,807 Catheter and seal assembly
- 8,578,889 Specimen alignment and head holding system for imaging machines
- 74/390,888 ASI Instruments & Design
Patents citing our Rodent Brain Matrix as a discovery tool:
- 7,915,280 Compounds and their uses
- 7,887,839 Oral formulations of glycyl-2-methylprolyl-glutamate
- RE41,150 Compounds and their use
- 7,605,177 Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
- 7,563,467 Use of an Opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
- 7,307,080 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
- 7,247,641 Compounds, derivatives, compositions, preparation and uses
- 7,235,557 Compounds and their uses
- 7,157,452 Subdtituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses
- 7,148,215 Chemical compounds
- 6,887,996 Compounds and their uses
- 6,848,597 Neuroprotective drug
- 6,723,733 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
- 6,716,828 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
- 6,638,954 .DELTA.2-1,2,3-TRIAZOLINE ANTICONVULSANTS AND THEIR ACTIVE METABOLITE ANALOGUES, THE AMINOALKYLPYRIDINES, ARE EXCITATORY AMINO ACID ANTAGONISTS AND ANTIISCHEMIC AGENTS, USEFUL IN THE TREATMENT OF CEREBRAL ISCHEMIA RESULTING FROM STROKE
- 6,635,642 PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
- 6,586,414 Treatment of cerebrovascular disease
- 6,545,011 Substituted 4,9-dihydrocyclopental[imn]phenanthridine-5-ones, derivatives thereof and their uses
- 6,514,983 Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
- 6,426,415 Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
- 6,245,757 Use of progestins to treat ischemic event
- 6,395,749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity
- 6,387,902 Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
- 6,380,211 Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
- 6,380,193 Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
- 6,630,347 Endothelial NOS transgenic animals and methods of use
- 6,316,403 Methods for treating an ischemic disorder and improving stroke outcome
- 6,315,995 Methods for treating an ischemic disorder and improving stroke outcome
- 6,310,270 Endothelial NOS knockout mice and methods of use
- 6,294,519 Method for treating ischemia
- 6,291,425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
- 6,235,748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
- 6,201,020 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
- 6,197,785 Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
- 6,150,401 Use of MEK1 inhibitors as protective agents against damage due to ischemia
- 6,121,278 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
- 5,733,871 Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
- 5,063,242 7-((substituted)amino) -8-((substituted)carbonyl)-methylamino-1-oxaspiro[4,5]decanes as diuretics antiinflammatory, and cerebrovascular agents
- 4,965,278 7-(substituted)amino)- 8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agents
Patents citing our Stereotaxic Instruments as a discovery tool:
- 8,092,791 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use
- 7,922,999 Administration of growth factor for tratment of CNS disorders
- 7,914,285 Method for treating drug and behavioral addictions
- 7,815,623 Stepped cannula
- 7,714,020 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
- 7,750,030 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
- 7,749,490 Mutant IL-10
- 7,723,472 Extracellular matrix binding chimeric proteins and methods of use thereof
- 7,622,256 Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/orVCAM-1
- 7,585,875 Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use
- 7,534,806 Method for treating neuropathic pain and associated syndromes
- 7,534,613 Methods of treating parkinson’s disease using viral vectors
- 7,261,882 Method for treating neuropathic pain by administering IL-10 polypeptides
- 6,953,575 Methods of treating central nervous system disorders using viral vectors
- 6,309,634 Methods of treating Parkinson’s disease using recombinant adeno-associated vector (rAAV)
- 6,172,088 Testosterone compounds and use for the protection of neurons
Patents citing our Multi-Barreled Pipettes as a discovery tool:
- 7,589,110 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
Link to United States Patent Office Official Site: www.uspto.gov